The New York Times (11/22, Schmall ) reported, “A company that makes clonazepam, a drug commonly prescribed for anxiety and seizures, has expanded its recall of some of the pills after it discovered that they were labeled with the wrong strength, the Food and Drug Administration announced.” According to the Times, “the company, Endo, recalled 16 product lots of clonazepam, a drug best known by the brand name Klonopin.” Endo “said it had not received any reports of adverse events related to the recall.”
Related Links: — “The New York Times (requires login and subscription)